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Abstract
Obesity has been associated with cognitive decline in longitudinal studies of older individuals. We
hypothesized that the cognitive sequelae of obesity may be detectable in the reproductive years. In
addition, we explored the hypothesis that these associations may be mediated by the hormonal
milieu.
In this study of 49 young healthy lean and overweight women aged 20–45, we investigated the
association between performance on a battery of cognitive tests, body composition parameters
(BMI, total fat, abdominal (visceral, subcutaneous and total) adipose tissue, and muscle), and
hormone levels (insulin, adiponectin, leptin, IGF-1, estrogen, testosterone, and vitamin D). We
found a significant negative association between both visceral adiposity and muscle, and
performance in the domain of verbal learning and memory, after controlling for age and education.
Other body composition parameters showed similar trends (0.05<p<0.10). Additionally, the
degree of insulin resistance was negatively associated with executive function domain. None of
the associations between the other hormones examined (adipokines, IGF-1, gonadal hormones and
vitamin D) and cognitive function were significant.
These preliminary findings suggest a possible association between obesity and cognitive function
in healthy young women of reproductive age. More research is warranted into the potential
modulatory effect of insulin resistance on this association.
Introduction
Obesity is a growing epidemic in the United States, with considerable impact on health care
expenditures, morbidity and mortality1. Over the past decade, obesity has been increasingly
associated with cognitive decline, particularly in older individuals. In cross-sectional studies,
elevated body mass index (BMI, kg/m2), as well as the metabolic syndrome, have been
associated with deficits in memory, executive function, processing speed, semantic fluency,
and overall cognitive function2–4. Detailed longitudinal studies have shown that elevated
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tBMI is an independent risk factor for accelerated brain atrophy, and increased risk of
cognitive decline, including Alzheimer’s disease 5–7.
In younger individuals, deficits in attention, executive function, verbal learning, verbal
memory and manual coordination have been noted with increasing BMI8–14. However, most
of these studies have focused either on adolescents14 or middle-aged adults (e.g. mean age
49 13), describe patients specifically presenting for treatment of their obesity 9,12, and use
limited measures of either cognitive outcome (e.g. executive function 10) or body
composition (e.g. BMI or waist-hip ratio 13).
The association between obesity and cognitive impairment may not result solely from such
known risk factors as dyslipidemia, hypertension, and endothelial dysfunction13. Recent
evidence suggests that the hormonal milieu associated with obesity may itself modulate
cognitive changes. Insulin resistance has been most frequently proposed as a regulator of
this process, likely because of the link between metabolic syndrome and cognitive
dysfunction15,16. Cognitive domains implicated include executive function 2, verbal
fluency17 and working memory18, 19. Similarly, the hormone insulin-like growth factor 1
(IGF-1) has been shown to exert neurophysiologic effects: it positively predicts cognitive
development among children 20, and may be neuroprotective against cognitive decline in the
middle and later years 21–23, but this has not been studied in premenopausal women. Studies
of other hormones, including adiponectin2,24, leptin25, estrogen 26, testosterone 27,28 and
vitamin D29 have shown more variable results, partially due to small sample sizes and
variable study design.
To our knowledge, this study is the first to investigate in detail the association of cognitive
function with weight and body composition in healthy 20–45 year old women, and to
explore hormonal correlates of this effect. We obtained detailed measures of cognitive
function, body composition variables, and hormonal profiles in overweight participants and
normal-weight controls. Our first aim was to test the hypothesis that even in young healthy
women, cognitive function is negatively associated with weight and body composition. Our
second aim, based on the emerging evidence for endocrine mediation outlined above, was to
explore associations between cognitive function and selected hormone levels.
Methods and Procedures
Subjects
Forty-nine eumenorrheic, healthy women were enrolled in the study. Thirty-seven of these
women had BMI ≥ 25 kg/m2 and waist circumference >88 cm, of whom 34 were a subset of
a cohort of 76 women entered in a longitudinal study examining the effects of growth
hormone replacement on abdominal obesity30. Because the present study was initiated after
the longitudinal one, only 34 of these women were enrolled, and they were enrolled
consecutively. The remaining women (N=12) were of normal weight, with 18 < BMI < 25
kg/m2. Subjects were recruited by advertisement. Inclusion criteria included age 20–45
years, BMI >18 kg/m2, and a complete set of body composition parameters available at
baseline. Exclusion criteria included English as a second language, color-blindness,
smoking, pregnancy or breastfeeding, hypothalamic or pituitary disorders, diabetes mellitus
or other chronic illnesses, estrogen or glucocorticoid use, use of statins or anti-
hypertensives, and a score of moderate or major depression on the Beck Depression
Inventory.
Protocol
The study was approved by the Partners Healthcare, Inc. Institutional Review Board, and
written, informed consent was obtained prior to initiating any procedures. Each subject was
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tadmitted to the Clinical Research Center at Massachusetts General Hospital for outpatient
testing. Fasting serum was drawn for insulin, glucose, gonadal hormones and adipokines
(see Biochemical Analysis), followed by a 75-g, 2-hour oral glucose tolerance test (OGTT)
to measure glucose and insulin at 30, 60, 90 and 120 minutes after glucose load. Cross-
sectional computed tomography (CT) and dual-energy x-ray absorptiometry (DXA) were
performed to measure body composition.
A detailed battery of cognitive tests was then administered. All cognitive scoring was
performed at the Massachusetts General Hospital Psychology Assessment Center. Initial
questions included age, years of education, and handedness. Additionally, participants
completed the Beck Depression Inventory (BDI), a 21-item self-report rating inventory
measuring characteristic attitudes and symptoms of depression. Then, subjects underwent
the following battery of standardized neuropsychological tests, which have been reviewed in
detail 31:
• Wechsler Test of Adult Reading (WTAR): measures adult reading as an estimate of
IQ
• Trail-Making Tests A and B:
– A: test of visual attention and tracking
– B: test of executive function requiring set shifting, alternately connecting
letters and numbers
• California Verbal Learning Test, Second Edition (CVLT-II): test of verbal learning
and memory
• Stroop test (D-KEFS version): test of selective attention, response inhibition and
set shifting
• Rey Complex Figure (RCF): test of visual construction, organization and
(nonverbal) memory
• Digit Symbol Substitution Test (DSS): test of executive function and processing
speed
• Verbal Fluency (D-KEFS version): test of behavioral initiation, lexical access and
set shifting
Biochemical Analyses
Serum samples were collected and stored at −80 °C. Serum total IGF-1 levels were
measured using a solid-phase enzyme-labeled chemiluminescent immunometric assay on the
Immulite 2000 automated immunoanalyzer (Siemens Medical Solutions Diagnostics, Los
Angeles, CA) with an inter-assay coefficient of variation (cv) of 3.7–4.2%. Estradiol,
glucose, insulin, and sex hormone binding globulin (SHBG) were measured by automated
immunoassay (Architect; Abbott Diagnostics, Chicago, IL). The lower limit of detection of
estradiol was 10 pg/ml, with an intra-assay cv of 1.4–6.4%. The lower limit of detection of
insulin was 1.0 NU/ml, with an intra-assay cv of 1.9–5.2% and with an inter-assay cv of
2.0–9.6%. The lower limit of detection of SHBG was 0.01 nmol/l, with an intra-assay cv of
5.65–9.54%. Serum testosterone levels were measured by a solid-phase radioimmunoassay
Coat-A-Count RIA kit (Siemens Medical Solutions Diagnostics, Los Angeles, CA) with a
minimum detection limit of 2.2 pg/ml and an intra-assay cv of 0.5–1.9%. Free testosterone
levels were calculated from total testosterone and SHBG using the laws of mass action32,
and free estradiol levels were calculated from total estradiol and SHBG using the laws of
mass action. Adiponectin (total and high molecular weight [HMW] forms) was measured by
enzyme-linked immunosorbent assay (ALPCO Diagnostics, Inc., Salem, NH), with an intra-
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tassay cv of less than 8%, and an inter-assay of less than 10%. Leptin was measured using an
ELISA kit (Millipore, Milwaukee, WI), with a sensitivity of 0.5 ng/ml, an intra-assay cv of
2.6–4.6%, and an inter-assay cv of 2.6–6.2%. Vitamin D was measured by an IDS-iSYS
Multi-Discipline Automated Analyzer based on chemiluminescence technology
(Immunodiagnostic Systems, Inc., Fountain Hills, AZ), with a minimum detection limit of
3.6 ng/ml and a within-run cv of 5.5 to 12.1%.
Body Composition Analysis
Body fat mass was determined with dual energy x-ray absorptiometry (DXA) using a
Hologic QDR 4500 scanner (Hologic Inc., Waltham, MA). Adipose tissue and muscle areas
were measured with a LightSpeed CT scanner (General Electric, Milwaukee, WI). Scan
parameters: 144 cm table height, 80kV (abdomen), 120 kV (thigh), 70 mA (abdomen), 170
mA (thigh), 1 cm slice thickness, scan time 2 seconds, 48 cm FOV. Single-slice cross-
sectional CT of the abdomen at the level of L4 was obtained to determine abdominal
subcutaneous adipose tissue (SAT), visceral adipose tissue (VAT), and total adipose tissue
(TAT). Single-slice cross-sectional CT of the left mid-thigh was obtained to determine fat
and muscle cross sectional areas (CSA). Analyses were performed using Alice software
(version 4.3.9 Parexel, Waltham, MA).
Statistical Analysis
Data were analyzed using the SAS software program JMP, version 8.0.1 (Cary, N.C.). Raw
cognitive test results were centered from the sample mean. Tests were then grouped into
specific cognitive domains. Cognitive domain z scores for each subject were calculated by
first summing the individual z scores for each of the test scores within the cognitive domain
subscales and then subtracting each participant’s score from the sample mean and dividing
by the standard deviation of the sample.
The cognitive domains are as follows:
1. Processing Speed: DSS, Stroop Color, Stroop Word
2. Executive function: Verbal Fluency Letter, Verbal Fluency Category
3. Verbal Learning and Memory: CVLT-II (Short Delay Free Recall; Short Delay
Cued Recall; Long Delay Free Recall; Long Delay Cued Recall; Trials 1–5)
4. Visual Memory: RCF Immediate, RCF Delayed
5. Visuospatial skills: RCF Copy
Additional cognitive outcomes were not included because they did not add any unique
explanatory power to the models.
Our primary analysis was to examine the association between BMI and other body
composition parameters, and cognitive outcomes. Our secondary analysis was to explore the
association between individual hormones and cognitive outcomes. Multivariate standard
least squares regressions were constructed between each cognitive domain z-score and
individual body composition (BMI, total adiposity (TAT), visceral adiposity (VAT),
subcutaneous adiposity (SAT), total fat, and muscle CSA) and hormones ((1) glucose
homeostasis, (2) IGF-1, (3) adipokines, (4) gonadal steroids, and (5) vitamin D), adjusting
for age and education. It should be noted that because a limited number of subjects had
adipokines drawn (adiponectin, N=30 and leptin, N=32), the N for these analyses was
consequently reduced. For each body composition parameter, the association with cognitive
scores was investigated both assuming a linear relationship and by categorizing the body
composition parameter into three groups. For BMI, WHO criteria were used to categorize
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tpatients into overweight and obese categories, and for other parameters tertiles were used to
categorize subjects. If the three groups were significantly different by overall ANOVA,
pairwise comparisons were performed. When a cognitive domain yielded a significant result,
then individual tests within those domains were examined using the same approach.
In addition to these primary analyses, three additional analyses were investigated to better
understand the combined relationship of body compositions measures and hormones. First,
given the effect of menstrual cycle on cognitive functioning 33, we completed all of the
previous analyses also adjusting for estradiol. Second, to assess the independent effect of
body composition measures on each cognitive measure with a significant association, the
original models for the body composition were also fit controlling for BMI. Third, for
hormones and body composition parameters revealing significant associations with
cognitive outcomes, we then included each individual body composition parameter in turn,
as well as each hormone, in the model to assess whether the body composition and
endocrine effects were independent. Additional analyses of the combined effects and
interactions among the hormones and body composition measures were not completed given
our limited sample size.
Results
1. Subject characteristics (Table 1)
Subjects had a mean age of 35 years, a mean BMI of 31.5 kg/m2, and had completed on
average at least 4 years of college education. Ninety percent were right-handed. All subjects
were normotensive. Overweight/obese women were on average older, less educated and
with lower WTAR scores than normal weight women; however none of these differences
was statistically significant.
2. Association between body composition parameters and cognitive function
In linear regression models with parameters treated as continuous variables, we found a
significant negative association between both VAT and muscle and performance in the
domain of verbal learning and memory, after controlling for age and education (Table 2).
All other markers of body composition examined also showed trends toward negative
associations with performance in this domain (0.05<p<0.10). Of the individual tests
examined, Trials 1–5 consistently revealed a statistically significant association with all
body composition markers. In linear regression models with parameters treated as
categorical, we found a significant negative association between SAT (p=0.010) and TAT
(p=0.019) and verbal learning and memory, but not for muscle (p=0.114), BMI (p=0.087),
VAT (p=0.143) or total fat (p=0.089). Figure 1 highlights these associations, with cognitive
outcomes adjusted for age and education. The domains of executive function, processing
speed, visuospatial skills and visual memory revealed no statistically significant associations
with any body composition parameters (Supplementary Table 1).
3. Association between endocrine markers and cognitive function
There was a statistically significant negative association between HOMA-IR and executive
function, in multivariate regressions performed for cognitive domains and individual
hormones, adjusting for age and education (r=0.322, p = 0.021, Figure 2). When the
individual tests of the executive domain were investigated, a statistically significant negative
association with DKEFS category was observed (partial r=−0.301, p=0.042), but not with
DKEFS letter (p=0.062). None of the other hormones examined revealed any significant
associations with cognitive outcomes after controlling for age and education (Supplementary
Table 2).
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t4. Combined effects of body composition and hormone levels on cognitive function
Given the associations above, several additional multivariate models were fit to investigate
the combined effect of the measures. First, all models were run with estradiol as an
additional predictor. The inclusion of estradiol did not change which body composition or
endocrine variables were found to be significantly associated with cognitive outcomes.
Given the considerable correlations between individual body composition parameters
(Supplementary Table 3), additional models were run with individual body composition
parameters adjusting for age, education and BMI to identify which measures had an
independent effect on verbal learning and memory. These revealed that neither BMI nor any
of the fat/muscle parameters (total fat, total muscle, TAT, SAT, VAT) was significant at
p<0.05 when both BMI and individual fat/muscle parameters were included in the model,
possibly reflecting colinearity between these measures.
Finally, given the correlation between HOMA-IR and individual body composition
parameters (Supplementary Table 3), two sets of additional models were run to examine
significant findings from Sections 2 and 3 above. In the first, in order to assess whether
HOMA-IR was independently associated with executive functioning when controlling for
the individual body composition measures, we fit separate regression models in each case.
When individual body composition markers were added into the model in turn, the
association between HOMA-IR and executive function domain remained significant when
controlling for muscle (p=0.022) and SAT (p=0.045), was suggestive for VAT, TAT and
BMI (0.05<p<0.06), and was not significant for total fat (p=0.103). When total testosterone
was added to the model including HOMA-IR, age and education, this measure showed a
trend toward an effect.
In the second, in order to assess whether body composition measures remained significantly
associated with cognitive performance after controlling for HOMA-IR, we fit separate
regression models in each case. In regression models with parameters treated as continuous,
controlling HOMA-IR as well as age and education, we continued to find a significant
negative association between performance in the verbal learning and memory domain for
VAT (p=0.0057) and muscle (p=0.009); the association was now also significant for TAT
(p=0.023) and remained suggestive for BMI, SAT and total fat (0.05<p<0.07). When
parameters were treated as categorical, VAT (p=0.041), muscle (p=0.0465) and TAT
(p=0.0061) remained significant; SAT (p=0.0022) and total fat (p=0.0363) were now
significant, and BMI remained suggestive (p=0.067). When we performed these analyses
controlling for HOMA-IR for all other cognitive function domains, only VAT when treated
as categorical but not as continuous, showed a significant association with performance in
the visual memory domain (p=0.020 and p=0.275, respectively).
Discussion
The major finding of this study is that in young, healthy, highly educated women of
reproductive age without comorbidities, body composition parameters associated with
obesity are negatively correlated with cognitive function in the domain of verbal learning
and memory. These findings may support an emerging body of literature linking obesity
with cognitive dysfunction not only in the elderly, who have comorbidities (hypertension,
hyperlipidemia, diabetes mellitus, cerebral microvascular disease), but also in the young10.
In this study, we administered a comprehensive battery of cognitive tests. Our subject
recruitment, from a healthy population of female volunteers aged 20–45, differs from other
small detailed studies of cognitive function in the young, either in (1) age group, where
mostly adolescents 14 or adults with mean age late 40s 13 have been described; (2) subject
recruitment from a healthy volunteer population rather than a clinic for obesity
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ttreatment 9,12, or (3) more detailed measures were used than prior measures of either
cognitive outcome (e.g. executive function10 or psychomotor speed11 ) and body
composition (e.g. BMI or waist-hip ratio13).
Additionally, we found a more significant association between detailed measurements of
body composition (visceral adiposity and muscle) and relative deficits in cognitive function,
than for BMI. These findings support the hypothesis that visceral adiposity may be a more
important contributor to dementia than is BMI per se 34. Although in older adults muscle
wasting is associated with cognitive decline35, in our study of younger women, muscle
cross-sectional area was negatively associated with cognitive function. This probably
reflects the fact that our subjects with higher BMIs also had higher amounts of muscle in
addition to higher amounts of fat, either from the increased thigh muscle required to support
increased weight, or from fatty infiltration of muscle. Supporting this hypothesis, we found
no associations between thigh muscle and verbal learning and memory when controlling for
BMI. To our knowledge no other studies have examined the relationship between muscle
and cognitive function in young healthy women, and these findings require replication and
further investigation.
While it is possible that even in young adults, cognitive function is affected by silent
cerebrovascular sequelae of obesity, hormonal correlates of cognitive function may be
important modulators. Insulin resistance in particular has been studied 15–17,19 and may
mediate cognitive function through modulation of hippocampal synaptic plasticity 36,
neuroinflammation and subsequent protein deposition 37, and may have gender-specific
effects due to interactions with gonadal steroids 38. Insulin resistance has been implicated in
cognitive dysfunction in neurologically normal older adults, even in the absence of silent
microvascular disease on MRI2. In this study, we found that HOMA-IR levels were
negatively correlated with executive function. Interestingly, when we controlled for HOMA-
IR, the association between body composition parameters and verbal learning and memory
remained, and for some parameters even became, significant, suggesting that several
mechanisms are at play. Additionally, while prior studies have shown that high levels of
serum IGF-1 appear to be both predictive of cognitive development among children 20 and
protective against cognitive decline in the middle and later years23, we did not detect any
association in this study.
In this exploratory analysis of endocrine markers of cognitive function, we investigated
whether the adipokines adiponectin, which is associated with insulin regulation and fatty
acid metabolism, and leptin, a hormone signaling appetite, were associated with cognitive
function, but detected no effect. Prior studies of adipokines and cognitive function, primarily
in the elderly, have yielded conflicting results2,24,25,39. The potential neuroprotective effects
of vitamin D metabolism have generated considerable research interest, with potential
positive effects of higher levels in the elderly29, but not definitively in adults aged 20–5940;
in this study, no association was noted. Finally, there has been intense interest in the effect
of sex hormones on cognition, especially with the decline in estrogen levels at menopause26.
Testosterone may also be neuroprotective, with middle levels of testosterone associated with
best cognitive functioning in the elderly 27, but studies in younger subjects have not shown
correlation between testosterone levels and cognitive tasks 28. In this study of young
individuals, gonadal hormones did not show any association with cognitive function
independently of age and education.
There were two main study limitations. First, the cross-sectional nature of the data precluded
inferring causality. Thus, we cannot ascertain whether relative cognitive dysfunction results
in behaviors leading to weight gain, or whether obesity causes relative cognitive
dysfunction. Second, there were small numbers overall in this exploratory study. We were
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tlikely underpowered to identify specific endocrine associations, albeit small, which in a
larger sample, might be statistically significant after controlling for age and education.
Effect sizes are provided in Supplementary Table 3 in order to facilitate power calculations
for future studies. Further, our limited sample size precluded us from fully investigating the
interactions among the hormones and body composition measures; future work with larger
sample sizes should investigate these interactions to understand the relationships between
these measures and cognitive functioning.
In summary, our exploratory analysis adds to an emerging understanding of the relationship
between obesity and cognitive function, and suggests that BMI, body composition and
possibly abnormalities in glucose and/or insulin homeostasis may contribute to decreased
cognitive function, even in young, otherwise healthy, women. Further research is required to
isolate the effects of individual hormones in the obesity milieu, from obesity itself.
Additionally, longitudinal prospective studies are required to determine causality.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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tFigure 1.
Plots of mean z-scores for verbal learning and memory domain, adjusted for age and
education, by body composition parameters.
Models for subcutaneous (SAT) and total (TAT) abdominal fat yielded significant
associations with verbal learning and memory (p=0.010 and p=0.019 respectively, but not
for BMI or muscle (p= 0.087 and p=0.114, respectively). For SAT and TAT, group
differences significant by student’s t test to p<0.05 are indicated with a *.
A. Subjects were divided by BMI, into normal (18<BMI<25 kg/m2, N=12), overweight by
WHO criteria (25 ≤ BMI<30 kg/m2, N=8) and obese by WHO criteria (BMI ≥ 30kg/m2,
N=29).
B. Subjects were divided by subcutaneous abdominal fat, with 1st tertile ranging from 7250
to 29570 mm2 (N=16), 2nd tertile ranging from 32430 to 47680 mm2 (N=16), and 3rd tertile
ranging from 47850 to 80010 mm2 (N=16).
C. Subjects were divided by total abdominal fat, with 1st tertile ranging from 10360 to
40220 mm2 (N=16), 2nd tertile ranging from 40750 to 59840 mm2 (N=16), and 3rd tertile
ranging from 60640 to 97300 mm2 (N=16).
D. Subjects were divided by muscle cross-sectional area, with 1st tertile ranging from 7578
to 12276 mm2 (N=16), 2nd tertile ranging from 12312 to 14539 mm2 (N=16), and 3rd tertile
ranging from 14743 to 18663 mm2 (N=16).
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tFigure 2.
Partial regression plot for executive function domain z score by HOMA-IR, adjusted for age
and education. Partial r = −0.34, p = 0.021.
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